ScoreWhy is Shanghai Medicilon, Inc. ?
1
Poor long term growth as Net Sales has grown by an annual rate of 13.65% and Operating profit at -226.73% over the last 5 years
2
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 83.33%, its profits have risen by 1%
- At the current price, the company has a high dividend yield of 0
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Miscellaneous)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Shanghai Medicilon, Inc. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Shanghai Medicilon, Inc.
66.03%
1.82
64.45%
China Shanghai Composite
13.33%
1.58
14.20%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
13.65%
EBIT Growth (5y)
-226.73%
EBIT to Interest (avg)
59.99
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
-0.05
Sales to Capital Employed (avg)
0.47
Tax Ratio
12.44%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
14.86%
ROE (avg)
11.56%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
4.23
EV to EBIT
-25.53
EV to EBITDA
-45.62
EV to Capital Employed
4.81
EV to Sales
8.08
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-18.85%
ROE (Latest)
-13.11%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
No Trend
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend13What is working for the Company
OPERATING CASH FLOW(Y)
Highest at CNY 99.89 MM
RAW MATERIAL COST(Y)
Fallen by -914.29% (YoY
NET SALES(Q)
Highest at CNY 302.56 MM
PRE-TAX PROFIT(Q)
At CNY -26.78 MM has Grown at 65.58%
NET PROFIT(Q)
At CNY -21.63 MM has Grown at 68.32%
-7What is not working for the Company
INTEREST(HY)
At CNY 4.79 MM has Grown at 20.76%
Here's what is working for Shanghai Medicilon, Inc.
Operating Cash Flow
Highest at CNY 99.89 MM
in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (CNY MM)
Net Sales
Highest at CNY 302.56 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (CNY MM)
Pre-Tax Profit
At CNY -26.78 MM has Grown at 65.58%
over average net sales of the previous four periods of CNY -77.79 MMMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (CNY MM)
Net Profit
At CNY -21.63 MM has Grown at 68.32%
over average net sales of the previous four periods of CNY -68.3 MMMOJO Watch
Near term Net Profit trend is positive
Net Profit (CNY MM)
Raw Material Cost
Fallen by -914.29% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Shanghai Medicilon, Inc.
Interest
At CNY 4.79 MM has Grown at 20.76%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (CNY MM)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
